WebJun 16, 2024 · About Ascletis. Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange (1672.HK). Ascletis is committed to developing and commercializing innovative drugs in the areas of NASH, cancer lipid metabolism and oral checkpoint inhibitors, and viral diseases to address unmet medical needs both in China … WebAug 18, 2024 · The firm’s clinical pipeline includes four candidates licensed in for development and commercialization within greater China. In November 2014, Ascletis negotiated a license to Presidio’s HCV ...
Ascletis Presented Positive Phase I Clinical Data for …
WebMar 16, 2024 · +86 57185389730 Company Ascletis Pharma Judy Wu Current Workplace Judy Wu has been working as a Director and A Vice President at Ascletis Pharma for 12 years. Ascletis Pharma is part of the Drug Stores & Pharmacies industry, and located in China. Ascletis Pharma Location Building D 198 Qidi Hipark Xiaoshan District Rd 12TH … WebAscletis Pharma Inc. 2,178 followers on LinkedIn. Innovative cures liberate life to the fullest Ascletis is an innovative R&D driven biotech listed on Hong Kong Stock Exchange … gpu hierarchy tom\\u0027s hardware
Alnylam Pharmaceuticals, Ascletis, Inc. Create Strategic …
WebAscletis Pharma contact info: Phone number: +86 57185389730 Website: www.ascletis.com What does Ascletis Pharma do? WebNov 7, 2024 · Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange (1672.HK), covering the entire value chain from discovery and development to manufacturing and commercialization. WebNov 17, 2024 · HANGZHOU and SHAOXING, China, Nov. 16, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the approval of the … gpu high 3d usage